StockClub
GDTCCytoMed Therapeutics Limited$ --
CytoMed Therapeutics Limited

CytoMed Therapeutics Limited

GDTC

$ -

-

You can review balance sheet highlights, composition, equity ratio trends, and annual balance sheet line items.

account_balanceBalance Sheet (BS) Summary

2025/12 Filed: 2026-03-31

Total Assets

account_balance
8M USD
No comparison

Shareholders' Equity

savings
6.5M USD
No comparison

Equity Ratio

pie_chart
82%
No comparison

Book Value Per Share

paid
0.56USD
No comparison

Asset & Liability Mix

Non-current AssetsCurrent AssetsEquityOtherNon-current LiabilitiesCurrent Liabilities

Equity Ratio Trend (5 Years)

Unit: %
200150100500
2021
2022
2023
2024
2025

Balance Sheet Details

Item
2019
2020
2021
2022
2023
2024
2025
Cash
Cash and Equivalents
Short-term Investments
Net Receivables
Inventory
Other Current Assets
Total Current Assets
2.10M
2.10M
0
132,054
0
0
3.66M
Goodwill
Intangible Assets
Property, Plant and Equipment
Property, Plant and Equipment Net
Long-term Investments
Other Assets
Other Non-current Assets
Net Tangible Assets
Non-current Assets Total
Total Assets
355
124,539
3.69M
3.69M
18,210
0
487,282
7.86M
4.32M
7.98M
Accounts Payable
Short-term Debt
Short/Current Long-term Debt
Current Deferred Revenue
Other Current Liabilities
Total Current Liabilities
124,742
40,847
40,847
182,807
25,064
709,169
Long-term Debt
Long-term Debt Total
Capital Lease Obligations
Other Non-current Liabilities
Net Debt
Non-current Liabilities Total
Total Liabilities
368,656
482,562
73,059
0
-1.61M
422,117
1.13M
Common Stock
Common Stock Shares Outstanding
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Other Stockholder Equity
Treasury Stock
Total Stockholder Equity
24.66M
11.65M
0
-18.83M
604,904
111,225
0
6.54M

Unlock Long-Term Balance Sheet Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.